Literature DB >> 16621325

The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature.

Marina G Falleti1, Paul Maruff, Pia Burman, Alan Harris.   

Abstract

OBJECTIVE: There is growing evidence in the neuropsychological literature that growth hormone (GH) deficiency is associated with cognitive impairment. There is also evidence that this impairment may be ameliorated with GH replacement therapy. The current study assessed the nature and severity of cognitive impairment associated with growth hormone deficiency, as well as effect of GH replacement on cognitive function by conducting a meta-analysis of the published literature to date.
METHOD: Thirteen studies met the inclusion criteria and these included: five cross-sectional studies investigating GH deficiency; and, eight (eight prospective, two of which also included cross-sectional comparisons) investigating GH replacement. Effect sizes (Cohen's d) falling into six cognitive domains were computed (separately for GH deficiency and GH replacement).
RESULTS: For GH deficiency, each of the cognitive domains assessed (besides language) showed moderate to large impairments when compared to matched controls (Effect sizes -0.46 to -1.46). For GH replacement, even though treated patients still performed moderately to largely below that of controls, when compared to their own baselines (as in prospective analyses), moderate improvements were found in cognitive performance, particularly attention and memory.
CONCLUSION: This meta-analysis clearly demonstrates the link between GH and cognitive performance, where poor performance can be ameliorated with GH treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621325     DOI: 10.1016/j.psyneuen.2006.01.005

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  41 in total

Review 1.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

2.  Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging.

Authors:  Michelle M Mielke; Stephen D Weigand; Heather J Wiste; Prashanthi Vemuri; Mary M Machulda; Davis S Knopman; Val Lowe; Rosebud O Roberts; Kejal Kantarci; Walter A Rocca; Clifford R Jack; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2014-11-15       Impact factor: 21.566

3.  High Postnatal Growth Hormone Levels Are Related to Cognitive Deficits in a Group of Children Born Very Preterm.

Authors:  Shannon E Scratch; Peter J Anderson; Lex W Doyle; Deanne K Thompson; Zohra M Ahmadzai; Ronda F Greaves; Terrie E Inder; Rodney W Hunt
Journal:  J Clin Endocrinol Metab       Date:  2015-05-14       Impact factor: 5.958

4.  Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome.

Authors:  Elisabeth M Dykens; Elizabeth Roof; Hailee Hunt-Hawkins
Journal:  J Child Psychol Psychiatry       Date:  2016-08-02       Impact factor: 8.982

5.  Performance of the CogState computerized battery in the Mayo Clinic Study on Aging.

Authors:  Michelle M Mielke; Mary M Machulda; Clinton E Hagen; Kelly K Edwards; Rosebud O Roberts; V Shane Pankratz; David S Knopman; Clifford R Jack; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2015-04-06       Impact factor: 21.566

6.  Neuropsychological recovery and quality-of-life in children and adolescents with growth hormone deficiency following TBI: a preliminary study.

Authors:  Julia B Wamstad; Kenneth W Norwood; Alan D Rogol; Matthew J Gurka; Mark D Deboer; James A Blackman; Marcia L Buck; Michelle N Kuperminc; Jodi G Darring; Peter D Patrick
Journal:  Brain Inj       Date:  2013       Impact factor: 2.311

7.  Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.

Authors:  Chris G Yedinak; Maria Fleseriu
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

8.  Functional Changes after Recombinant Human Growth Hormone Replacement in Patients with Chronic Traumatic Brain Injury and Abnormal Growth Hormone Secretion.

Authors:  Kurt A Mossberg; William J Durham; Dennis J Zgaljardic; Charles R Gilkison; Christopher P Danesi; Melinda Sheffield-Moore; Brent E Masel; Randall J Urban
Journal:  J Neurotrauma       Date:  2016-10-13       Impact factor: 5.269

9.  Low and Normal IGF-1 Levels in Patients with Chronic Medical Disorders (CMD) is Independent of Anterior Pituitary Hormone Deficiencies: Implications for Treating IGF-1 Abnormal Deficiencies with CMD.

Authors:  E Braverman; M Oscar-Berman; R Lohmann; R Kennedy; M Kerner; K Dushaj; K Blum
Journal:  J Genet Syndr Gene Ther       Date:  2013-02-09

10.  Growth hormone deficiency and cerebral palsy.

Authors:  Jesús Devesa; Nerea Casteleiro; Cristina Rodicio; Natalia López; Pedro Reimunde
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.